Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

The hereditary genetic testing market has seen rapid development recently, driven by advances in technology and growing awareness of genetic disorders. With increasing acceptance of molecular diagnostics and expanding healthcare infrastructure, this sector is set for continued robust growth. Below, we explore the market’s current size, key growth drivers, segmentation, notable industry players, and regional dynamics shaping its future.

Hereditary Genetic Testing Market Size and Projected Growth

The hereditary genetic testing market has experienced significant expansion, rising from $23.88 billion in 2025 to $26.56 billion in 2026 at a compound annual growth rate (CAGR) of 11.2%. This upward trend is largely the result of heightened incidence of hereditary diseases, broader clinical use of molecular diagnostic tools, growth in diagnostic labs, increased public awareness about genetic conditions, and improved accessibility of basic genetic testing technologies. Looking ahead, the market is anticipated to grow even faster, reaching $40.12 billion by 2030 with a CAGR of 10.9%. This forecasted surge will be supported by breakthroughs in next-generation sequencing, rising demand for personalized medicine, expansion of pharmacogenomics, growing healthcare investments in preventive care, and wider use of genetic counseling services. Key trends expected to influence this growth include the increasing use of preventive and predictive genetic testing, early cancer risk assessment, the rise of direct-to-consumer testing services, expanded prenatal and newborn screening, and greater recognition of inherited cardiovascular and rare disorders.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20559&type=smp

Factors Driving Growth in the Hereditary Genetic Testing Market

One major factor boosting the hereditary genetic testing market is the rising prevalence of cancer, a group of diseases characterized by abnormal cell growth that can spread throughout the body. This rise is attributed to an aging population, lifestyle changes, environmental factors, genetic predispositions, and advancements in diagnostic methods. Hereditary genetic testing plays a crucial role in cancer prevention by detecting gene mutations linked to increased risk, which enables early monitoring and targeted prevention strategies. For instance, according to Macmillan Cancer Support in August 2024, over 3 million people in the UK are living with cancer in 2024, with projections estimating this will rise to 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040. This growing cancer burden is a key impetus for expanding hereditary genetic testing services.

Segmentation Insights: Key Areas of Opportunity in the Hereditary Genetic Testing Market

The hereditary genetic testing market is categorized into several segments based on various parameters. By type, it includes predictive and presymptomatic testing, carrier testing, prenatal and newborn testing, diagnostic testing, pharmacogenomic testing, and other types. Technologically, it is divided into cytogenetic testing, biochemical testing, and molecular testing. Clinical applications encompass cancer genetic testing, cardiovascular genetic testing, neurological genetic testing, and rare diseases genetic testing. The market also segments by end users into hospitals and clinics, diagnostic laboratories, research institutes, and direct-to-consumer genetic testing companies. Further subcategories detail various specialized testing services within these broader groups, such as genetic screening for inherited disorders, non-invasive prenatal testing, newborn screening, genetic testing for drug responses, and wellness or ancestry testing.

Access The Complete Hereditary Genetic Testing Market Report:

https://www.thebusinessresearchcompany.com/report/hereditary-genetic-testing-global-market-report

How Innovation and Advanced Genomic Solutions Shape Market Competition

Leading companies in the hereditary genetic testing market are concentrating on developing sophisticated genomic tools such as multi-cancer multigene panels to improve early detection and enable precision therapies. Multi-cancer multigene panels analyze numerous genes simultaneously to identify mutations linked with different cancer types, helping guide diagnosis and personalized treatment. For example, in February 2024, US-based Exact Sciences Corporation introduced the Riskguard hereditary cancer test. This test provides a personalized report on gene-specific and familial cancer risks for 10 common cancers using a simple blood or saliva sample. It assists in assessing cancer risk, facilitating screening and treatment decisions, and evaluating risks for family members, as well as supporting tailored treatment strategies for diagnosed patients.

Major Market Players and Their Roles in the Hereditary Genetic Testing Sector

Key participants shaping the hereditary genetic testing industry include well-established companies such as F. Hoffmann-La Roche Ltd., Abbott Laboratories, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Eurofins Scientific SE, Hologic Inc., Exact Sciences Corporation, Fulgent Genetics Inc., BioReference Laboratories Inc., BGI Group, Invitae Corporation, Color Health Inc., MedGenome Inc., Devyser AB, Mapmygenome India Ltd., Igenomix S.L.P., Myriad Genetics Inc., Natera Inc., Ambry Genetics Corporation, GeneDx LLC, Centogene N.V., CooperSurgical Inc., and Sema4. These firms are driving innovation and expanding access to hereditary genetic testing worldwide.

Regional Analysis: North America Leads Hereditary Genetic Testing Market

In 2025, North America held the largest share of the hereditary genetic testing market and is also predicted to be the fastest-growing region during the forecast period. The market report encompasses detailed analyses across various geographies including Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, providing a comprehensive understanding of regional trends and growth prospects.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model